{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T19:09:24Z","timestamp":1792091364097,"version":"4.4.0"},"reference-count":83,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,11,21]]},"DOI":"10.7759\/cureus.97459","type":"journal-article","created":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T18:42:16Z","timestamp":1763750536000},"source":"Crossref","is-referenced-by-count":2,"title":["Exploring the Interplay Between Hypertension and Osteoporosis: A Narrative Review"],"prefix":"10.7759","author":[{"given":"Yolanda","family":"Gutierrez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald  A","family":"Shaju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alyssa","family":"Sepulveda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seval","family":"Coban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1097\/01.hjh.0000410246.59221.b1","article-title":"Mortality patterns in hypertension","volume":"29 Suppl 1","author":"Arima H","year":"2011","unstructured":"Arima H, Barzi F, Chalmers J. Mortality patterns in hypertension. J Hypertens. 2011, 29 Suppl 1:S3-7. 10.1097\/01.hjh.0000410246.59221.b1","journal-title":"J Hypertens"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)32225-6","article-title":"Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"392","year":"2018","unstructured":"Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990-2017. a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018, 392:1923-94. 10.1016\/S0140-6736(18)32225-6","journal-title":"Lancet"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3803\/EnM.2021.301","article-title":"Long-term treatment of postmenopausal osteoporosis","volume":"36","author":"Brown JP","year":"2021","unstructured":"Brown JP. Long-term treatment of postmenopausal osteoporosis. Endocrinol Metab (Seoul). 2021, 36:544-52. 10.3803\/EnM.2021.301","journal-title":"Endocrinol Metab (Seoul)"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24043772","article-title":"Oxidative stress and inflammation in osteoporosis: molecular mechanisms involved and the relationship with microRNAs","volume":"24","author":"Iantomasi T","year":"2023","unstructured":"Iantomasi T, Romagnoli C, Palmini G, et al.. Oxidative stress and inflammation in osteoporosis: molecular mechanisms involved and the relationship with microRNAs. Int J Mol Sci. 2023, 24:3772. 10.3390\/ijms24043772","journal-title":"Int J Mol Sci"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ejcn.1600870","article-title":"The influence of smoking on vitamin D status and calcium metabolism","volume":"53","author":"Brot C","year":"1999","unstructured":"Brot C, Jorgensen NR, Sorensen OH. The influence of smoking on vitamin D status and calcium metabolism. Eur J Clin Nutr. 1999, 53:920-6. 10.1038\/sj.ejcn.1600870","journal-title":"Eur J Clin Nutr"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-014-2879-y","article-title":"Alcohol consumption and hip fracture risk","volume":"26","author":"Zhang X","year":"2015","unstructured":"Zhang X, Yu Z, Yu M, Qu X. Alcohol consumption and hip fracture risk. Osteoporos Int. 2015, 26:531-42. 10.1007\/s00198-014-2879-y","journal-title":"Osteoporos Int"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcna.2020.06.004","article-title":"Osteoporosis in older adults","volume":"104","author":"Johnston CB","year":"2020","unstructured":"Johnston CB, Dagar M. Osteoporosis in older adults. Med Clin North Am. 2020, 104:873-84. 10.1016\/j.mcna.2020.06.004","journal-title":"Med Clin North Am"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1486188","article-title":"Mendelian randomization studies of risk and protective factors for osteoporosis: a systematic review and meta-analysis","volume":"15","author":"Ji W","year":"2024","unstructured":"Ji W, Pan B, Chen X, Lao Z, Yang W, Qian Y. Mendelian randomization studies of risk and protective factors for osteoporosis: a systematic review and meta-analysis. Front Endocrinol (Lausanne). 2024, 15:1486188. 10.3389\/fendo.2024.1486188","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-021-05900-y","article-title":"The clinician's guide to prevention and treatment of osteoporosis","volume":"33","author":"LeBoff MS","year":"2022","unstructured":"LeBoff MS, Greenspan SL, Insogna KL, Lewiecki EM, Saag KG, Singer AJ, Siris ES. The clinician's guide to prevention and treatment of osteoporosis. Osteoporos Int. 2022, 33:2049-102. 10.1007\/s00198-021-05900-y","journal-title":"Osteoporos Int"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(99)01437-3","article-title":"High blood pressure and bone-mineral loss in elderly White women: a prospective study. Study of Osteoporotic Fractures Research Group","volume":"354","author":"Cappuccio FP","year":"1999","unstructured":"Cappuccio FP, Meilahn E, Zmuda JM, Cauley JA. High blood pressure and bone-mineral loss in elderly White women: a prospective study. Study of Osteoporotic Fractures Research Group. Lancet. 1999, 354:971-5. 10.1016\/s0140-6736(99)01437-3","journal-title":"Lancet"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-021-06190-0","article-title":"Elevated blood pressure, antihypertensive medications and bone health in the population: revisiting old hypotheses and exploring future research directions","volume":"33","author":"Canoy D","year":"2022","unstructured":"Canoy D, Harvey NC, Prieto-Alhambra D, et al.. Elevated blood pressure, antihypertensive medications and bone health in the population: revisiting old hypotheses and exploring future research directions. Osteoporos Int. 2022, 33:315-26. 10.1007\/s00198-021-06190-0","journal-title":"Osteoporos Int"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2023.1142155","article-title":"The role of hypertension in bone mineral density among males older than 50 years and postmenopausal females: evidence from the US National Health and Nutrition Examination Survey, 2005-2010","volume":"11","author":"Li S","year":"2023","unstructured":"Li S, Li L, Feng A, et al.. The role of hypertension in bone mineral density among males older than 50 years and postmenopausal females: evidence from the US National Health and Nutrition Examination Survey, 2005-2010. Front Public Health. 2023, 11:1142155. 10.3389\/fpubh.2023.1142155","journal-title":"Front Public Health"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.121.318063","article-title":"Oxidative stress and hypertension","volume":"128","author":"Griendling KK","year":"2021","unstructured":"Griendling KK, Camargo LL, Rios FJ, Alves-Lopes R, Montezano AC, Touyz RM. Oxidative stress and hypertension. Circ Res. 2021, 128:993-1020. 10.1161\/CIRCRESAHA.121.318063","journal-title":"Circ Res"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.cjca.2020.02.081","article-title":"Oxidative stress: a unifying paradigm in hypertension","volume":"36","author":"Touyz RM","year":"2020","unstructured":"Touyz RM, Rios FJ, Alves-Lopes R, Neves KB, Camargo LL, Montezano AC. Oxidative stress: a unifying paradigm in hypertension. Can J Cardiol. 2020, 36:659-70. 10.1016\/j.cjca.2020.02.081","journal-title":"Can J Cardiol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1210\/er.2009-0024","article-title":"From estrogen-centric to aging and oxidative stress: a revised perspective of the pathogenesis of osteoporosis","volume":"31","author":"Manolagas SC","year":"2010","unstructured":"Manolagas SC. From estrogen-centric to aging and oxidative stress: a revised perspective of the pathogenesis of osteoporosis. Endocr Rev. 2010, 31:266-300. 10.1210\/er.2009-0024","journal-title":"Endocr Rev"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1038\/sigtrans.2017.23","article-title":"NF-\u03baB signaling in inflammation","volume":"2","author":"Liu T","year":"2017","unstructured":"Liu T, Zhang L, Joo D, Sun SC. NF-\u03baB signaling in inflammation. Signal Transduct Target Ther. 2017, 2:17023-. 10.1038\/sigtrans.2017.23","journal-title":"Signal Transduct Target Ther"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1611932","article-title":"Oxidative stress and\u2002inflammation: roles in osteoporosis","volume":"16","author":"Luo J","year":"2025","unstructured":"Luo J, Li L, Shi W, Xu K, Shen Y, Dai B. Oxidative stress and\u2002inflammation: roles in osteoporosis. Front Immunol. 2025, 16:1611932. 10.3389\/fimmu.2025.1611932","journal-title":"Front Immunol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241511963","article-title":"The relationship between renin-angiotensin-aldosterone system (RAAS) activity, osteoporosis and estrogen deficiency in type 2 diabetes","volume":"24","author":"Mkhize BC","year":"2023","unstructured":"Mkhize BC, Mosili P, Ngubane PS, Sibiya NH, Khathi A. The relationship between renin-angiotensin-aldosterone system (RAAS) activity, osteoporosis and estrogen deficiency in type 2 diabetes. Int J Mol Sci. 2023, 24:10.3390\/ijms241511963","journal-title":"Int J Mol Sci"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1096\/fj.201802805RR","article-title":"Activation of ROS\/MAPKs\/NF-\u03baB\/NLRP3 and inhibition of efferocytosis in osteoclast-mediated diabetic osteoporosis","volume":"33","author":"An Y","year":"2019","unstructured":"An Y, Zhang H, Wang C, et al.. Activation of ROS\/MAPKs\/NF-\u03baB\/NLRP3 and inhibition of efferocytosis in osteoclast-mediated diabetic osteoporosis. FASEB J. 2019, 33:12515-27. 10.1096\/fj.201802805RR","journal-title":"FASEB J"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-07014-0","article-title":"Bone matrix components activate the NLRP3 inflammasome and promote osteoclast differentiation","volume":"7","author":"Alippe Y","year":"2017","unstructured":"Alippe Y, Wang C, Ricci B, et al.. Bone matrix components activate the NLRP3 inflammasome and promote osteoclast differentiation. Sci Rep. 2017, 7:6630. 10.1038\/s41598-017-07014-0","journal-title":"Sci Rep"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.vph.2017.05.005","article-title":"Oxidative stress and reactive oxygen species in endothelial dysfunction associated with cardiovascular and metabolic diseases","volume":"100","author":"Incalza MA","year":"2018","unstructured":"Incalza MA, D'Oria R, Natalicchio A, Perrini S, Laviola L, Giorgino F. Oxidative stress and reactive oxygen species in endothelial dysfunction associated with cardiovascular and metabolic diseases. Vascul Pharmacol. 2018, 100:1-19. 10.1016\/j.vph.2017.05.005","journal-title":"Vascul Pharmacol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1038\/hr.2010.264","article-title":"The role of oxidative stress in the pathophysiology of hypertension","volume":"34","author":"Rodrigo R","year":"2011","unstructured":"Rodrigo R, Gonz\u00e1lez J, Paoletto F. The role of oxidative stress in the pathophysiology of hypertension. Hypertens Res. 2011, 34:431-40. 10.1038\/hr.2010.264","journal-title":"Hypertens Res"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.3390\/nu14193968","article-title":"Exercise training attenuates hypertension via suppressing ROS\/MAPK\/NF-\u03bab\/at-1R pathway in the hypothalamic paraventricular nucleus","volume":"14","author":"Qi J","year":"2022","unstructured":"Qi J, Li RJ, Fu LY, et al.. Exercise training attenuates hypertension via suppressing ROS\/MAPK\/NF-\u03bab\/at-1R pathway in the hypothalamic paraventricular nucleus. Nutrients. 2022, 14:3968. 10.3390\/nu14193968","journal-title":"Nutrients"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvy252","article-title":"Pharmacological inhibition of the NLRP3 inflammasome reduces blood pressure, renal damage, and dysfunction in salt-sensitive hypertension","volume":"115","author":"Krishnan SM","year":"2019","unstructured":"Krishnan SM, Ling YH, Huuskes BM, et al.. Pharmacological inhibition of the NLRP3 inflammasome reduces blood pressure, renal damage, and dysfunction in salt-sensitive hypertension. Cardiovasc Res. 2019, 115:776-87. 10.1093\/cvr\/cvy252","journal-title":"Cardiovasc Res"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1038\/s41569-023-00964-1","article-title":"Immune and inflammatory mechanisms in hypertension","volume":"21","author":"Guzik TJ","year":"2024","unstructured":"Guzik TJ, Nosalski R, Maffia P, Drummond GR. Immune and inflammatory mechanisms in hypertension. Nat Rev Cardiol. 2024, 21:396-416. 10.1038\/s41569-023-00964-1","journal-title":"Nat Rev Cardiol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1161\/01.hyp.25.3.443","article-title":"Locally generated angiotensin II in the adrenal gland regulates basal, corticotropin-, and potassium-stimulated aldosterone secretion","volume":"25","author":"Gupta P","year":"1995","unstructured":"Gupta P, Franco-Saenz R, Mulrow PJ. Locally generated angiotensin II in the adrenal gland regulates basal, corticotropin-, and potassium-stimulated aldosterone secretion. Hypertension. 1995, 25:443-8. 10.1161\/01.hyp.25.3.443","journal-title":"Hypertension"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1098\/rsif.2017.0327","article-title":"Differential cell-matrix mechanoadaptations and inflammation drive regional propensities to aortic fibrosis, aneurysm or dissection in hypertension","volume":"14","author":"Bersi MR","year":"2017","unstructured":"Bersi MR, Khosravi R, Wujciak AJ, Harrison DG, Humphrey JD. Differential cell-matrix mechanoadaptations and inflammation drive regional propensities to aortic fibrosis, aneurysm or dissection in hypertension. J R Soc Interface. 2017, 14:20170327. 10.1098\/rsif.2017.0327","journal-title":"J R Soc Interface"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1172\/JCI7818","article-title":"Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice","volume":"105","author":"Daugherty A","year":"2000","unstructured":"Daugherty A, Manning MW, Cassis LA. Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice. J Clin Invest. 2000, 105:1605-12. 10.1172\/JCI7818","journal-title":"J Clin Invest"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00038.2017","article-title":"Angiotensin II signal transduction: an update on mechanisms of physiology and pathophysiology","volume":"98","author":"Forrester SJ","year":"2018","unstructured":"Forrester SJ, Booz GW, Sigmund CD, et al.. Angiotensin II signal transduction: an update on mechanisms of physiology and pathophysiology. Physiol Rev. 2018, 98:1627-738. 10.1152\/physrev.00038.2017","journal-title":"Physiol Rev"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1007\/s00774-020-01132-y","article-title":"Role of the renin-angiotensin-aldosterone system in bone metabolism","volume":"38","author":"Mo C","year":"2020","unstructured":"Mo C, Ke J, Zhao D, Zhang B. Role of the renin-angiotensin-aldosterone system in bone metabolism. J Bone Miner Metab. 2020, 38:772-9. 10.1007\/s00774-020-01132-y","journal-title":"J Bone Miner Metab"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-0716-1669-7_16","article-title":"Methods to analyze the roles of TAK1, TRAF6, and Nemo in the regulation of NF-\u03bab signaling by rank stimulation during osteoclastogenesis","volume":"2366","author":"Swarnkar G","year":"2021","unstructured":"Swarnkar G, Arra M, Adapala S, Abu-Amer Y. Methods to analyze the roles of TAK1, TRAF6, and Nemo in the regulation of NF-\u03bab signaling by rank stimulation during osteoclastogenesis. Methods Mol Biol. 2021, 2366:267-82. 10.1007\/978-1-0716-1669-7_16","journal-title":"Methods Mol Biol"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-014-2992-y","article-title":"Local renin-angiotensin system is associated with bone mineral density of glucocorticoid-induced osteoporosis patients","volume":"26","author":"Shuai B","year":"2015","unstructured":"Shuai B, Yang YP, Shen L, et al.. Local renin-angiotensin system is associated with bone mineral density of glucocorticoid-induced osteoporosis patients. Osteoporos Int. 2015, 26:1063-71. 10.1007\/s00198-014-2992-y","journal-title":"Osteoporos Int"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22094924","article-title":"Paeonolide as a novel regulator of core-binding factor subunit alpha-1 in bone-forming cells","volume":"22","author":"Park KR","year":"2021","unstructured":"Park KR, Lee JY, Cho M, Hong JT, Yun HM. Paeonolide as a novel regulator of core-binding factor subunit alpha-1 in bone-forming cells. Int J Mol Sci. 2021, 22:10.3390\/ijms22094924","journal-title":"Int J Mol Sci"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2019.115041","article-title":"The angiotensin converting enzyme 2\/angiotensin-(1-7)\/Mas receptor axis as a key player in alveolar bone remodeling","volume":"128","author":"Queiroz-Junior CM","year":"2019","unstructured":"Queiroz-Junior CM, Santos AC, Galv\u00e3o I, Souto GR, Mesquita RA, S\u00e1 MA, Ferreira AJ. The angiotensin converting enzyme 2\/angiotensin-(1-7)\/Mas receptor axis as a key player in alveolar bone remodeling. Bone. 2019, 128:115041. 10.1016\/j.bone.2019.115041","journal-title":"Bone"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-02570-x","article-title":"Angiotensin (1-7) ameliorates the structural and biochemical alterations of ovariectomy-induced osteoporosis in rats via activation of ACE-2\/Mas receptor axis","volume":"7","author":"Abuohashish HM","year":"2017","unstructured":"Abuohashish HM, Ahmed MM, Sabry D, Khattab MM, Al-Rejaie SS. Angiotensin (1-7) ameliorates the structural and biochemical alterations of ovariectomy-induced osteoporosis in rats via activation of ACE-2\/Mas receptor axis. Sci Rep. 2017, 7:2293. 10.1038\/s41598-017-02570-x","journal-title":"Sci Rep"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1093\/jbmr\/zjaf118","article-title":"Advances in parathyroid hormone-based medicines","volume":"40","author":"Bonnet AL","year":"2025","unstructured":"Bonnet AL, Aboishava L, Mannstadt M. Advances in parathyroid hormone-based medicines. J Bone Miner Res. 2025, 40:1195-206. 10.1093\/jbmr\/zjaf118","journal-title":"J Bone Miner Res"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2024.6542","article-title":"The Women\u2019s Health Initiative randomized trials and clinical practice: a review","volume":"331","author":"Manson JE","year":"2024","unstructured":"Manson JE, Crandall CJ, Rossouw JE, et al.. The Women\u2019s Health Initiative randomized trials and clinical practice: a review. JAMA. 2024, 331:1748-60. 10.1001\/jama.2024.6542","journal-title":"JAMA"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1097\/MED.0b013e32831a46d6","article-title":"Parathyroid hormone treatment for osteoporosis","volume":"15","author":"Cosman F","year":"2008","unstructured":"Cosman F. Parathyroid hormone treatment for osteoporosis. Curr Opin Endocrinol Diabetes Obes. 2008, 15:495-501. 10.1097\/MED.0b013e32831a46d6","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1007\/s11914-014-0248-6","article-title":"Lifestyle and osteoporosis","volume":"13","author":"Zhu K","year":"2015","unstructured":"Zhu K, Prince RL. Lifestyle and osteoporosis. Curr Osteoporos Rep. 2015, 13:52-9. 10.1007\/s11914-014-0248-6","journal-title":"Curr Osteoporos Rep"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000333.pub2","article-title":"Exercise for preventing and treating osteoporosis in postmenopausal women","author":"Howe TE","year":"2011","unstructured":"Howe TE, Shea B, Dawson LJ, et al.. Exercise for preventing and treating osteoporosis in postmenopausal women. Cochrane Database Syst Rev. 2011, CD000333. 10.1002\/14651858.CD000333.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"ref41","article-title":"Risk factors for osteoporosis and associated fractures","volume":"104 Suppl","author":"Kelsey JL","year":"1989","unstructured":"Kelsey JL. Risk factors for osteoporosis and associated fractures. Public Health Rep. 1989, 104 Suppl:14-20.","journal-title":"Public Health Rep"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1016\/j.nutres.2008.12.002","article-title":"Low-sodium dietary approaches to stop hypertension-type diet including lean red meat lowers blood pressure in postmenopausal women","volume":"29","author":"Nowson CA","year":"2009","unstructured":"Nowson CA, Wattanapenpaiboon N, Pachett A. Low-sodium dietary approaches to stop hypertension-type diet including lean red meat lowers blood pressure in postmenopausal women. Nutr Res. 2009, 29:8-18. 10.1016\/j.nutres.2008.12.002","journal-title":"Nutr Res"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1093\/jn\/133.10.3130","article-title":"The DASH diet and sodium reduction improve markers of bone turnover and calcium metabolism in adults","volume":"133","author":"Lin PH","year":"2003","unstructured":"Lin PH, Ginty F, Appel LJ, et al.. The DASH diet and sodium reduction improve markers of bone turnover and calcium metabolism in adults. J Nutr. 2003, 133:3130-6. 10.1093\/jn\/133.10.3130","journal-title":"J Nutr"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.3390\/ijms12074206","article-title":"Reciprocal roles of angiotensin II and angiotensin II receptors blockade (ARB) in regulating CBFA1\/RANKL via cAMP signaling pathway: possible mechanism for hypertension-related osteoporosis and antagonistic effect of ARB on hypertension-related osteoporosis","volume":"12","author":"Guan XX","year":"2011","unstructured":"Guan XX, Zhou Y, Li JY. Reciprocal roles of angiotensin II and angiotensin II receptors blockade (ARB) in regulating CBFA1\/RANKL via cAMP signaling pathway: possible mechanism for hypertension-related osteoporosis and antagonistic effect of ARB on hypertension-related osteoporosis. Int J Mol Sci. 2011, 12:4206-13. 10.3390\/ijms12074206","journal-title":"Int J Mol Sci"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1007\/s00223-012-9671-9","article-title":"The relationship among hypertension, antihypertensive medications, and osteoporosis: a narrative review","volume":"92","author":"Ili\u0107 K","year":"2013","unstructured":"Ili\u0107 K, Obradovi\u0107 N, Vujasinovi\u0107-Stupar N. The relationship among hypertension, antihypertensive medications, and osteoporosis: a narrative review. Calcif Tissue Int. 2013, 92:217-27. 10.1007\/s00223-012-9671-9","journal-title":"Calcif Tissue Int"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.123.21648","article-title":"Advanced progress of the relationship between antihypertensive drugs and bone metabolism","volume":"80","author":"Zhang R","year":"2023","unstructured":"Zhang R, Yin H, Yang M, Lei X, Zhen D, Zhang Z. Advanced progress of the relationship between antihypertensive drugs and bone metabolism. Hypertension. 2023, 80:2255-64. 10.1161\/HYPERTENSIONAHA.123.21648","journal-title":"Hypertension"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S179568","article-title":"Effectiveness of thiazides on serum and urinary calcium levels and bone mineral density in patients with osteoporosis: a systematic review and meta-analysis","volume":"12","author":"Cheng L","year":"2018","unstructured":"Cheng L, Zhang K, Zhang Z. Effectiveness of thiazides on serum and urinary calcium levels and bone mineral density in patients with osteoporosis: a systematic review and meta-analysis. Drug Des Devel Ther. 2018, 12:3929-35. 10.2147\/DDDT.S179568","journal-title":"Drug Des Devel Ther"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-006-0259-y","article-title":"The effect of treatment with a thiazide diuretic for 4 years on bone density in normal postmenopausal women","volume":"18","author":"Bolland MJ","year":"2007","unstructured":"Bolland MJ, Ames RW, Horne AM, Orr-Walker BJ, Gamble GD, Reid IR. The effect of treatment with a thiazide diuretic for 4 years on bone density in normal postmenopausal women. Osteoporos Int. 2007, 18:479-86. 10.1007\/s00198-006-0259-y","journal-title":"Osteoporos Int"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2007030348","article-title":"Thiazide diuretics directly induce osteoblast differentiation and mineralized nodule formation by interacting with a sodium chloride co-transporter in bone","volume":"18","author":"Dvorak MM","year":"2007","unstructured":"Dvorak MM, De Joussineau C, Carter DH, et al.. Thiazide diuretics directly induce osteoblast differentiation and mineralized nodule formation by interacting with a sodium chloride co-transporter in bone. J Am Soc Nephrol. 2007, 18:2509-16. 10.1681\/ASN.2007030348","journal-title":"J Am Soc Nephrol"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.2779","article-title":"Parathyroid hormone and the use of diuretics and calcium\u2010channel blockers: the multi\u2010ethnic study of atherosclerosis","volume":"31","author":"Zaheer S","year":"2016","unstructured":"Zaheer S, de Boer I, Allison M, et al.. Parathyroid hormone and the use of diuretics and calcium\u2010channel blockers: the multi\u2010ethnic study of atherosclerosis. J Bone Miner Res. 2016, 31:1137-45. 10.1002\/jbmr.2779","journal-title":"J Bone Miner Res"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1038\/hr.2011.143","article-title":"Cilnidipine, but not amlodipine, ameliorates osteoporosis in ovariectomized hypertensive rats through inhibition of the N-type calcium channel","volume":"35","author":"Shimizu H","year":"2012","unstructured":"Shimizu H, Nakagami H, Yasumasa N, et al.. Cilnidipine, but not amlodipine, ameliorates osteoporosis in ovariectomized hypertensive rats through inhibition of the N-type calcium channel. Hypertens Res. 2012, 35:77-81. 10.1038\/hr.2011.143","journal-title":"Hypertens Res"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1038\/hr.2009.99","article-title":"Prevention of osteoporosis by angiotensin-converting enzyme inhibitor in spontaneous hypertensive rats","volume":"32","author":"Shimizu H","year":"2009","unstructured":"Shimizu H, Nakagami H, Osako MK, et al.. Prevention of osteoporosis by angiotensin-converting enzyme inhibitor in spontaneous hypertensive rats. Hypertens Res. 2009, 32:786-90. 10.1038\/hr.2009.99","journal-title":"Hypertens Res"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1248\/bpb.24.628","article-title":"Effects of various antihypertensive drugs on the function of osteoblast","volume":"24","author":"Nishiya Y","year":"2001","unstructured":"Nishiya Y, Sugimoto S. Effects of various antihypertensive drugs on the function of osteoblast. Biol Pharm Bull. 2001, 24:628-33. 10.1248\/bpb.24.628","journal-title":"Biol Pharm Bull"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1902\/jop.2004.75.2.268","article-title":"Influence of age on combined effects of cyclosporin and nifedipine on rat alveolar bone","volume":"75","author":"Spolidorio LC","year":"2004","unstructured":"Spolidorio LC, Spolidorio DM, Nassar PO, Nassar CA, Holzhausen M, Almeida OP. Influence of age on combined effects of cyclosporin and nifedipine on rat alveolar bone. J Periodontol. 2004, 75:268-72. 10.1902\/jop.2004.75.2.268","journal-title":"J Periodontol"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2005.09.011","article-title":"Angiotensin converting enzyme inhibitor use is associated with higher bone mineral density in elderly Chinese","volume":"38","author":"Lynn H","year":"2006","unstructured":"Lynn H, Kwok T, Wong SY, Woo J, Leung PC. Angiotensin converting enzyme inhibitor use is associated with higher bone mineral density in elderly Chinese. Bone. 2006, 38:584-8. 10.1016\/j.bone.2005.09.011","journal-title":"Bone"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/9067167","article-title":"The effect of the angiotensin-converting enzyme inhibitor on bone health in castrated hypertensive rats is mediated via the kinin-kallikrein system","volume":"2022","author":"Zhang N","year":"2022","unstructured":"Zhang N, Huo Y, Yao C, Sun J, Zhang Y. The effect of the angiotensin-converting enzyme inhibitor on bone health in castrated hypertensive rats is mediated via the kinin-kallikrein system. J Renin Angiotensin Aldosterone Syst. 2022, 2022:9067167. 10.1155\/2022\/9067167","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1007\/s00774-010-0209-9","article-title":"Captopril improves osteopenia in ovariectomized rats and promotes bone formation in osteoblasts","volume":"29","author":"Liu YY","year":"2011","unstructured":"Liu YY, Yao WM, Wu T, Xu BL, Chen F, Cui L. Captopril improves osteopenia in ovariectomized rats and promotes bone formation in osteoblasts. J Bone Miner Metab. 2011, 29:149-58. 10.1007\/s00774-010-0209-9","journal-title":"J Bone Miner Metab"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2017.05.062","article-title":"ACE-2\/Ang1-7\/Mas cascade mediates ACE inhibitor, captopril, protective effects in estrogen-deficient osteoporotic rats","volume":"92","author":"Abuohashish HM","year":"2017","unstructured":"Abuohashish HM, Ahmed MM, Sabry D, Khattab MM, Al-Rejaie SS. ACE-2\/Ang1-7\/Mas cascade mediates ACE inhibitor, captopril, protective effects in estrogen-deficient osteoporotic rats. Biomed Pharmacother. 2017, 92:58-68. 10.1016\/j.biopha.2017.05.062","journal-title":"Biomed Pharmacother"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2025.117710","article-title":"Angiotensin receptor blockers (ARBs) but not angiotensin converting enzyme inhibitors (ACE-Is) are associated with lower osteoclast activity and higher bone mineral density: Results from the TUDA study","volume":"203","author":"Fitzpatrick D","year":"2025","unstructured":"Fitzpatrick D, Laird E, Ward M, et al.. Angiotensin receptor blockers (ARBs) but not angiotensin converting enzyme inhibitors (ACE-Is) are associated with lower osteoclast activity and higher bone mineral density: Results from the TUDA study. Bone. 2025, 203:117710. 10.1016\/j.bone.2025.117710","journal-title":"Bone"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/7581110","article-title":"Angiotensin receptor blocker is associated with a lower fracture risk: an updated systematic review and meta-analysis","volume":"2022","author":"Wu J","year":"2022","unstructured":"Wu J, Wang M, Guo M, Du XY, Tan XZ, Teng FY, Xu Y. Angiotensin receptor blocker is associated with a lower fracture risk: an updated systematic review and meta-analysis. Int J Clin Pract. 2022, 2022:7581110. 10.1155\/2022\/7581110","journal-title":"Int J Clin Pract"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2019.12.069","article-title":"The association between renin angiotensin aldosterone system blockers and future osteoporotic fractures in a hypertensive population - a population-based cohort study in Taiwan","volume":"305","author":"Kao YT","year":"2020","unstructured":"Kao YT, Huang CY, Fang YA, Liu JC. The association between renin angiotensin aldosterone system blockers and future osteoporotic fractures in a hypertensive population - a population-based cohort study in Taiwan. Int J Cardiol. 2020, 305:147-53. 10.1016\/j.ijcard.2019.12.069","journal-title":"Int J Cardiol"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.1186\/s12891-023-07102-5","article-title":"The impact of renin-angiotensin system inhibitors on bone fracture risk: a nationwide nested case-control study","volume":"25","author":"Kim KM","year":"2024","unstructured":"Kim KM, Hwang EJ, Lee S, Yoon JH. The impact of renin-angiotensin system inhibitors on bone fracture risk: a nationwide nested case-control study. BMC Musculoskelet Disord. 2024, 25:3. 10.1186\/s12891-023-07102-5","journal-title":"BMC Musculoskelet Disord"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.2271","article-title":"Risk of osteoporotic fractures with angiotensin II receptor blockers versus angiotensin-converting enzyme inhibitors in hypertensive community-dwelling elderly","volume":"29","author":"Butt DA","year":"2014","unstructured":"Butt DA, Mamdani M, Gomes T, Lix L, Lu H, Tu K. Risk of osteoporotic fractures with angiotensin II receptor blockers versus angiotensin-converting enzyme inhibitors in hypertensive community-dwelling elderly. J Bone Miner Res. 2014, 29:2483-8. 10.1002\/jbmr.2271","journal-title":"J Bone Miner Res"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.1007\/s00223-022-01004-9","article-title":"Fracture risk and use of angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers","volume":"111","author":"Holloway-Kew KL","year":"2022","unstructured":"Holloway-Kew KL, Betson AG, Anderson KB, et al.. Fracture risk and use of angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers. Calcif Tissue Int. 2022, 111:396-408. 10.1007\/s00223-022-01004-9","journal-title":"Calcif Tissue Int"},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.1159\/000464461","article-title":"Angiotensin II\/angiotensin II receptor blockade affects osteoporosis via the AT1\/AT2-mediated cAMP-dependent PKA pathway","volume":"204","author":"Zhou Y","year":"2017","unstructured":"Zhou Y, Guan X, Chen X, et al.. Angiotensin II\/angiotensin II receptor blockade affects osteoporosis via the AT1\/AT2-mediated cAMP-dependent PKA pathway. Cells Tissues Organs. 2017, 204:25-37. 10.1159\/000464461","journal-title":"Cells Tissues Organs"},{"key":"ref66","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2012.11.019","article-title":"2013 ACCF\/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"61","author":"O'Gara PT","year":"2013","unstructured":"O'Gara PT, Kushner FG, Ascheim DD, et al.. 2013 ACCF\/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2013, 61:e78-e140. 10.1016\/j.jacc.2012.11.019","journal-title":"J Am Coll Cardiol"},{"key":"ref67","doi-asserted-by":"publisher","DOI":"10.1111\/fcp.12779","article-title":"Telmisartan: an angiotensin receptor blocker regulates osteoclastogenesis via inhibition of the ERK triggering in osteoporotic male rats","volume":"36","author":"Mahmoud MA","year":"2022","unstructured":"Mahmoud MA, Safar MM, Agha AM, Khattab MM, Saleh DO. Telmisartan: an angiotensin receptor blocker regulates osteoclastogenesis via inhibition of the ERK triggering in osteoporotic male rats. Fundam Clin Pharmacol. 2022, 36:869-78. 10.1111\/fcp.12779","journal-title":"Fundam Clin Pharmacol"},{"key":"ref68","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2019.172519","article-title":"Blockade of the angiotensin II type 1 receptor increases bone mineral density and left ventricular contractility in a mouse model of juvenile Paget disease","volume":"859","author":"Tsuruda T","year":"2019","unstructured":"Tsuruda T, Funamoto T, Udagawa N, et al.. Blockade of the angiotensin II type 1 receptor increases bone mineral density and left ventricular contractility in a mouse model of juvenile Paget disease. Eur J Pharmacol. 2019, 859:172519. 10.1016\/j.ejphar.2019.172519","journal-title":"Eur J Pharmacol"},{"key":"ref69","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1164387","article-title":"Association of antihypertensive drugs with fracture and bone mineral density: a comprehensive drug-target Mendelian randomization study","volume":"14","author":"Huang X","year":"2023","unstructured":"Huang X, Zhang T, Guo P, Gong W, Zhu H, Zhao M, Yuan Z. Association of antihypertensive drugs with fracture and bone mineral density: a comprehensive drug-target Mendelian randomization study. Front Endocrinol (Lausanne). 2023, 14:1164387. 10.3389\/fendo.2023.1164387","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref70","doi-asserted-by":"publisher","DOI":"10.1093\/ageing\/afw150","article-title":"ARB users exhibit a lower fracture incidence than ACE inhibitor users among older hypertensive men","volume":"46","author":"Kwok T","year":"2017","unstructured":"Kwok T, Leung J, Barrett-Connor E. ARB users exhibit a lower fracture incidence than ACE inhibitor users among older hypertensive men. Age Ageing. 2017, 46:57-64. 10.1093\/ageing\/afw150","journal-title":"Age Ageing"},{"key":"ref71","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-020-02348-8","article-title":"Spironolactone reduces biochemical markers of bone turnover in postmenopausal women with primary aldosteronism","volume":"69","author":"Adolf C","year":"2020","unstructured":"Adolf C, Braun LT, Fuss CT, et al.. Spironolactone reduces biochemical markers of bone turnover in postmenopausal women with primary aldosteronism. Endocrine. 2020, 69:625-33. 10.1007\/s12020-020-02348-8","journal-title":"Endocrine"},{"key":"ref72","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2015.3204","article-title":"Amiloride inhibits osteoclastogenesis by suppressing nuclear factor-\u03baB and mitogen-activated protein kinase activity in receptor activator of nuclear factor-\u03baB-induced RAW264.7 cells","volume":"11","author":"Wang X","year":"2015","unstructured":"Wang X, Zhu Y, Zheng S, et al.. Amiloride inhibits osteoclastogenesis by suppressing nuclear factor-\u03baB and mitogen-activated protein kinase activity in receptor activator of nuclear factor-\u03baB-induced RAW264.7 cells. Mol Med Rep. 2015, 11:3451-6. 10.3892\/mmr.2015.3204","journal-title":"Mol Med Rep"},{"key":"ref73","doi-asserted-by":"publisher","DOI":"10.1172\/JCI122151","article-title":"Sympathetic \u03b21-adrenergic signaling contributes to regulation of human bone metabolism","volume":"128","author":"Khosla S","year":"2018","unstructured":"Khosla S, Drake MT, Volkman TL, et al.. Sympathetic \u03b21-adrenergic signaling contributes to regulation of human bone metabolism. J Clin Invest. 2018, 128:4832-42. 10.1172\/JCI122151","journal-title":"J Clin Invest"},{"key":"ref74","doi-asserted-by":"publisher","DOI":"10.2147\/CIA.S60669","article-title":"Long-term effects of antihypertensive medications on bone mineral density in men older than 55 years","volume":"9","author":"A\u011fa\u00e7ayak KS","year":"2014","unstructured":"A\u011fa\u00e7ayak KS, G\u00fcven S, Koparal M, G\u00fcne\u015f N, Atalay Y, At\u0131lgan S. Long-term effects of antihypertensive medications on bone mineral density in men older than 55 years. Clin Interv Aging. 2014, 9:509-13. 10.2147\/CIA.S60669","journal-title":"Clin Interv Aging"},{"key":"ref75","doi-asserted-by":"publisher","DOI":"10.1080\/09513590600850300","article-title":"Effects of raloxifene therapy on plasma renin and aldosterone levels and blood pressure in postmenopausal women","volume":"22","author":"Morgante G","year":"2006","unstructured":"Morgante G, Delia A, Musacchio MC, Severi FM, Petraglia F, De Leo V. Effects of raloxifene therapy on plasma renin and aldosterone levels and blood pressure in postmenopausal women. Gynecol Endocrinol. 2006, 22:376-80. 10.1080\/09513590600850300","journal-title":"Gynecol Endocrinol"},{"key":"ref76","doi-asserted-by":"publisher","DOI":"10.1111\/j.1447-0594.2009.00562.x","article-title":"Effects of raloxifene on the renin-angiotensin-aldosterone system and blood pressure in hypertensive and normotensive osteoporotic postmenopausal women","volume":"10","author":"Sumino H","year":"2010","unstructured":"Sumino H, Ichikawa S, Kasama S, et al.. Effects of raloxifene on the renin-angiotensin-aldosterone system and blood pressure in hypertensive and normotensive osteoporotic postmenopausal women. Geriatr Gerontol Int. 2010, 10:70-7. 10.1111\/j.1447-0594.2009.00562.x","journal-title":"Geriatr Gerontol Int"},{"key":"ref77","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26104552","article-title":"Role of sclerostin in cardiovascular system","volume":"26","author":"Zhang N","year":"2025","unstructured":"Zhang N, Wang L, Li X, et al.. Role of sclerostin in cardiovascular system. Int J Mol Sci. 2025, 26:4552. 10.3390\/ijms26104552","journal-title":"Int J Mol Sci"},{"key":"ref78","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aay6570","article-title":"Evaluating the cardiovascular safety of sclerostin inhibition using evidence from meta-analysis of clinical trials and human genetics","volume":"12","author":"Bovijn J","year":"2020","unstructured":"Bovijn J, Krebs K, Chen CY, et al.. Evaluating the cardiovascular safety of sclerostin inhibition using evidence from meta-analysis of clinical trials and human genetics. Sci Transl Med. 2020, 12:eaay6570. 10.1126\/scitranslmed.aay6570","journal-title":"Sci Transl Med"},{"key":"ref79","doi-asserted-by":"publisher","DOI":"10.1038\/s41440-025-02372-z","article-title":"Investigation of risk factors for osteoporosis with a focus on hypertension and estimation of the causal effect of hypertension on osteoporosis using causal forest","author":"Uematsu T","year":"2025","unstructured":"Uematsu T, Nojiri S, Urasaki W, Nishizaki Y. Investigation of risk factors for osteoporosis with a focus on hypertension and estimation of the causal effect of hypertension on osteoporosis using causal forest. Hypertens Res. 2025, 10.1038\/s41440-025-02372-z","journal-title":"Hypertens Res"},{"key":"ref80","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-58691-7","article-title":"High blood pressure is associated with increased risk of future fracture, but not vice versa","volume":"14","author":"Du XP","year":"2024","unstructured":"Du XP, Zheng ML, Yang XC, Zheng ML. High blood pressure is associated with increased risk of future fracture, but not vice versa. Sci Rep. 2024, 14:8005. 10.1038\/s41598-024-58691-7","journal-title":"Sci Rep"},{"key":"ref81","doi-asserted-by":"publisher","DOI":"10.1186\/s12891-021-04124-9","article-title":"Hypertension is associated with osteoporosis: a case-control study in Chinese postmenopausal women","volume":"22","author":"Chai H","year":"2021","unstructured":"Chai H, Ge J, Li L, Li J, Ye Y. Hypertension is associated with osteoporosis: a case-control study in Chinese postmenopausal women. BMC Musculoskelet Disord. 2021, 22:253. 10.1186\/s12891-021-04124-9","journal-title":"BMC Musculoskelet Disord"},{"key":"ref82","doi-asserted-by":"publisher","DOI":"10.1172\/JCI184325","article-title":"Hypertension promotes bone loss and fragility by favoring bone resorption in mouse models","volume":"135","author":"Hennen EM","year":"2025","unstructured":"Hennen EM, Uppuganti S, de la Visitaci\u00f3n N, et al.. Hypertension promotes bone loss and fragility by favoring bone resorption in mouse models. J Clin Invest. 2025, 135:e184325. 10.1172\/JCI184325","journal-title":"J Clin Invest"},{"key":"ref83","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-023-06756-0","article-title":"Association between clinical use of nifedipine and the risk of osteoporosis: a nationwide retrospective cohort study","volume":"34","author":"Chang CM","year":"2023","unstructured":"Chang CM, Chen YC, Wu WT, Lin TK, Chou YC, Lin MH, Sun CA. Association between clinical use of nifedipine and the risk of osteoporosis: a nationwide retrospective cohort study. Osteoporos Int. 2023, 34:1223-30. 10.1007\/s00198-023-06756-0","journal-title":"Osteoporos Int"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/425115-exploring-the-interplay-between-hypertension-and-osteoporosis-a-narrative-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T18:42:17Z","timestamp":1763750537000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/425115-exploring-the-interplay-between-hypertension-and-osteoporosis-a-narrative-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,21]]},"references-count":83,"URL":"https:\/\/doi.org\/10.7759\/cureus.97459","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11,21]]}}}